Evaluating long-term outcomes in patients with ischemic heart disease undergoing CABG or PCI
Registry for Long-term Clinical Outcomes and Prognostic Factors in Patient With Coronary Artery Disease Undergoing Coronary Artery Bypass Graft Surgery or Percutaneous Coronary Intervention With Second Generation Drug-Eluting Stent
This study is trying to see how well coronary artery bypass surgery and stent placement work for people with heart disease over the long term.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 10000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Samsung Medical Center Academic / other |
| Locations | 1 site (Seoul) |
| Trial ID | NCT03870815 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the long-term clinical outcomes and prognostic factors in patients with coronary artery disease who have undergone either coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI) with drug-eluting stents. It seeks to understand the effectiveness and safety of these treatment strategies in light of the declining use of CABG and the increasing preference for PCI. The study will analyze data from patients suspected of having ischemic heart disease who have received these interventions, providing insights into contemporary practices and outcomes. By comparing the results of CABG and PCI, the study hopes to contribute valuable information to current treatment guidelines.
Who should consider this trial
Good fit: Ideal candidates for this study are patients suspected of having ischemic heart disease who have undergone CABG or PCI with drug-eluting stents.
Not a fit: Patients under the age of 18 will not benefit from this study as they are excluded from participation.
Why it matters
Potential benefit: If successful, this study could provide critical insights into the long-term effectiveness of CABG versus PCI, potentially guiding treatment decisions for patients with ischemic heart disease.
How similar studies have performed: Previous studies have shown varying outcomes between CABG and PCI, but this study aims to provide contemporary data that reflects current practices, making it a valuable addition to existing literature.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients who suspected ischemic heart disease and underwent CABG or PCI with DES Exclusion Criteria: * Age \< 18 years
Where this trial is running
Seoul
- Samsung Medical Center — Seoul, Korea, Republic of (Recruiting)
Study contacts
- Principal investigator: Young Bin Song, MD, PhD — Samsung Medical Center
- Study coordinator: Young Bin Song, MD, PhD
- Email: youngbin.song@gmail.com
- Phone: 82-2-3410-3419
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.